UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

PloS one, 2020-11, Vol.15 (11), p.e0242544-e0242544

2020

Volltextzugriff (PDF)

Lysozyme M―Positive Monocytes Mediate Angiotensin II―Induced Arterial Hypertension and Vascular Dysfunction

Circulation (New York, N.Y.), 2011-09, Vol.124 (12), p.1370-1381

2011

Volltextzugriff (PDF)

Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany

Supportive care in cancer, 2021-07, Vol.29 (7), p.3753-3765

2021

Volltextzugriff (PDF)

Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience

Annals of hematology, 2023-05, Vol.102 (5), p.1045-1052

2023

Volltextzugriff (PDF)

Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.420-435

2019

Volltextzugriff (PDF)

Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy

PloS one, 2019-01, Vol.14 (1), p.e0210991

2019

Volltextzugriff (PDF)

Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Leukemia, 2022-10, Vol.36 (10), p.2396-2407

2022

Volltextzugriff (PDF)

Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy

PloS one, 2019-09, Vol.14 (9), p.e0223013-e0223013

2019

Volltextzugriff (PDF)

Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study

BMC research notes, 2024-05, Vol.17 (1), p.137-137, Article 137

2024

Volltextzugriff (PDF)

Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018

BMC pulmonary medicine, 2023-01, Vol.23 (1), p.16-16, Article 16

2023

Volltextzugriff (PDF)

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

European journal of cancer (1990), 2024-04, Vol.201, p.113911-113911, Article 113911

2024

Volltextzugriff (PDF)

Early‐onset venous thromboembolisms in newly diagnosed non‐promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy

European journal of haematology, 2023-04, Vol.110 (4), p.426-434

2023

Volltextzugriff (PDF)

Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy

European journal of haematology, 2022-02, Vol.108 (2), p.125-132

2022

Volltextzugriff (PDF)

Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations

Annals of hematology, 2022-08, Vol.101 (8), p.1703-1710

2022

Volltextzugriff (PDF)

Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Leukemia, 2022-12, Vol.36 (12), p.2950-2950

2022

Volltextzugriff (PDF)

KRAS Mutations in Squamous Cell Carcinomas of the Lung

Frontiers in oncology, 2021-12, Vol.11, p.788084-788084

2021

Volltextzugriff (PDF)

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

Journal of cancer research and clinical oncology, 2023-09, Vol.149 (11), p.9243-9252

2023

Volltextzugriff (PDF)

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

Frontiers in oncology, 2023-09, Vol.13, p.1273478-1273478

2023

Volltextzugriff (PDF)

SCLC, Paraneoplastic Syndromes, and the Immune System

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.1878-1880

2019

Volltextzugriff (PDF)

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma

Journal of cancer research and clinical oncology, 2022-06, Vol.148 (6), p.1465-1472

2022

Volltextzugriff (PDF)

Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221097191-17588359221097191

2022

Volltextzugriff (PDF)

Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study

VASA, 2023-01, Vol.52 (1), p.38-45

2023

Volltextzugriff (PDF)

Platelet Aggregation Testing on a Routine Coagulation Analyzer: A Method Comparison Study

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619885184-1076029619885184

2019

Volltextzugriff (PDF)

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

Lung cancer (Auckland), 2019-07, Vol.10, p.67-80

2019

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Englisch
(95)
Deutsch
(20)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

Lysozyme M―Positive Monocytes Mediate Angiotensin II―Induced Arterial Hypertension and Vascular Dysfunction

Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany

Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience

Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study

Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy

Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study

Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

Early‐onset venous thromboembolisms in newly diagnosed non‐promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy

Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy

Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations

Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

KRAS Mutations in Squamous Cell Carcinomas of the Lung

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

SCLC, Paraneoplastic Syndromes, and the Immune System

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma

Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study

Platelet Aggregation Testing on a Routine Coagulation Analyzer: A Method Comparison Study

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

Suchergebnisse filtern